Journal profile

Journal of the National Comprehensive Cancer Network : JNCCN

Publisher: Harborside Press
ISSN1540-1405 | 1540-1413 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.26
Citation rate 8.16 5,771 total citations
h5-index 86 h5 depth signal
Cited share 38.2% 288 of 754
Total citations 5,771 Citation footprint
Metric signal 7.55 External metric anchor
Self-citation 0.3% 18 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 2,387
China 131
Canada 126
United Kingdom 83
India 76

Citing Fields of Research

Oncology 1,570
Breast Cancer 471
Palliative Care 323
Lung Cancer 309
Hematology 258

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 5,313 Articles tracked across the journal lifetime
Indexed publication set 754 288 cited publications
Last 12 months 545 45.4 publications/month
Open access share 0.9% 5 OA publications in the last year
Leading citing country United States 2,387 citing publications
Leading citing field Oncology 1,570 citing publications
Latest tracked publication 13 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, Jan. 2003-
PubMed
v1n1, Jan. 2003-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Oncology Lung Cancer Breast Cancer Lymphomas Hematology Palliative Care

Issuing & Sponsoring Bodies

Contributor
National Comprehensive Cancer Network (U.S.)

Broad Categories

Neoplasms Lung Cancer Hematology Palliative Care Breast Cancer Immunology Liver & Colon Cancer Lymphomas

MeSH Descriptors

Neoplasms

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Open DOI
Dharmesh Gopalakrishnan, Yu Fujiwara, Katharine A. Collier et al.
Background: Metastatic sarcomatoid renal cell carcinoma (msRCC) is an aggressive disease typically associated with poor outcomes following VEGF-targeted therapies. This study evaluated in real-world outcomes in patients with msRCC based ...
03
Open DOI
Elizabeth Cathcart-Rake, Kelliann C. Fee-Schroeder, Caroline Davidge-Pitts et al.
Background: This qualitative study sought to understand factors related to low rates of screening mammography among transgender and gender-diverse (TGD) individuals and how these rates might be improved. Methods: Individuals who self-rep...
06
Open DOI
Rozalyn L. Rodwin, John A. Kairalla, Emily Hibbitts et al.
Background: Treatment for B-cell acute lymphoblastic leukemia (B-ALL) lasts >2 years and can impact families. The Children’s Oncology Group multicenter therapeutic trial AALL0932 randomized patients with NCI standard-risk, average-risk B...
08
Open DOI
Al B. Benson, Michael I. D’ANgelica, Aijaz Ahmed et al.
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver. The NCCN Guidelines for HCC provide recommendations for the comprehensive care of patients with HCC, including screening, evaluation, treatment, and surveilla...

Bibliographical & Catalog Notes

Title from cover.

Supplements accompany some vols.

Also issued online.

v.4, no. 5 (Sept. 2005)20050922 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper